Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Advocates often emphasize the potential for significant therapeutic gains, principally in conditions where conventional therapies have proven inadequate. However, this is to assess the substantial financial burden associated with CPI stem cell therapy,